[HTML][HTML] The role of thyroglobulin in preoperative and postoperative evaluation of patients with differentiated thyroid cancer
S Li, C Ren, Y Gong, F Ye, Y Tang, J Xu… - Frontiers in …, 2022 - frontiersin.org
Thyroglobulin (Tg) is secreted by thyroid follicular cells and stored in the thyroid follicular
lumen as a component of thyroid hormone. It is known that both benign and well …
lumen as a component of thyroid hormone. It is known that both benign and well …
Radio-iodide treatment: from molecular aspects to the clinical view
A De la Vieja, G Riesco-Eizaguirre - Cancers, 2021 - mdpi.com
Simple Summary This year marks the 80th commemoration of the first time that radio-iodide
treatment (RAI) was used. RAI is one of the most effective targeted internal radiation …
treatment (RAI) was used. RAI is one of the most effective targeted internal radiation …
Outcomes of patients with an intermediate-risk group according to the Japanese risk classification of papillary thyroid carcinoma
K Horiuchi, M Fujimoto, K Hidenori, Y Yoshida… - World Journal of …, 2023 - Springer
Background The management of intermediate-risk group of papillary thyroid cancer (PTC) is
still vague, particularly regarding whether or not total thyroidectomy, postoperative …
still vague, particularly regarding whether or not total thyroidectomy, postoperative …
[HTML][HTML] Appraisal of radioiodine refractory thyroid cancer: advances and challenges
H Liu, D Yang, L Li, Y Tu, C Chen… - American Journal of …, 2020 - ncbi.nlm.nih.gov
The incidence of thyroid cancer ranks top among all endocrine cancers, which has
increased worldwide. Some patients suffer from recurrent/residual diseases after primary …
increased worldwide. Some patients suffer from recurrent/residual diseases after primary …
[HTML][HTML] Assessment of different radioiodine doses for post-ablation therapy of thyroid remnants: A systematic review
M Ansari, MR Tavirani - Iranian Journal of Pharmaceutical …, 2022 - ncbi.nlm.nih.gov
The determination of radioiodine remnant ablation (RRA) dosage in post-operation thyroid
residual tissues resection has been largely subject of discussion, yet no concise conclusion …
residual tissues resection has been largely subject of discussion, yet no concise conclusion …
[HTML][HTML] Radioiodine (131I) treatment decision-making for low-and intermediate-risk differentiated thyroid cancer
H Gao, J Huang, Q Dai, J Su - Archives of Endocrinology and …, 2023 - SciELO Brasil
Objective: The purpose of this study was to investigate the effect and influencing factors of
post-surgical radioactive iodine (RAI) therapy for patients with low-and intermediate-risk …
post-surgical radioactive iodine (RAI) therapy for patients with low-and intermediate-risk …
SEPCT/CT在分化型甲状腺癌诊治的增益价值及高剂量131Ⅰ的治疗疗效
何清， 史育红， 王朝点 - 分子影像学杂志, 2021 - j-fzyx.com
目的探讨单光子发射型计算机断层显像与CT (SEPCT/CT) 在分化型甲状腺癌诊治的增益价值及
高剂量131 Ⅰ 方法选取2018 年1 月~ 2020 年1 月在我院治疗的分化型甲状腺癌患者125 例 …
高剂量131 Ⅰ 方法选取2018 年1 月~ 2020 年1 月在我院治疗的分化型甲状腺癌患者125 例 …
[HTML][HTML] Radioactive iodine treatment of papillary thyroid carcinoma in Japan
T Okamoto, Y Omi, Y Yoshida, K Horiuchi, K Abe - Gland Surgery, 2020 - ncbi.nlm.nih.gov
We have a unique history of using radioactive iodine (RAI) therapy and surgical treatment for
thyroid cancer in Japan. Less than total thyroidectomy without RAI therapy was the most …
thyroid cancer in Japan. Less than total thyroidectomy without RAI therapy was the most …
[HTML][HTML] Factors Affecting Ablation Success After I-131 Radioactive Iodine Therapy in Low and Intermediate Risk Papillary Thyroid Cancer
S Goksel, U Avci - Hormone and Metabolic Research, 2023 - thieme-connect.com
The study was to evaluate the effect of radioactive iodine (RAI) treatment application time
and clinical, histopathological factors on ablation success in patients with operated papillary …
and clinical, histopathological factors on ablation success in patients with operated papillary …
Ablation rates and long term outcome following low dose radioiodine for differentiated thyroid cancer in the West of Scotland: a retrospective analysis
K Graham, F Tough, H Belikova, I Wotherspoon… - Endocrine Practice, 2024 - Elsevier
Objective Low dose radioiodine is an accepted means of remnant ablation in patients with
low to intermediate risk differentiated thyroid cancer (DTC) based on the results of several …
low to intermediate risk differentiated thyroid cancer (DTC) based on the results of several …